The Enterprise Value as of September 2024 (TTM) for Brii Biosciences Limited (BRIBF) is -394860553.00

According to Brii Biosciences Limited’s latest financial reports and current stock price. The company's current Enterprise Value is -394860553.00. This represents a change of -175.87% compared to the average of 520.47M of the last 4 quarters.

Brii Biosciences Limited (BRIBF) Historical Enterprise Value (quarterly & annually)

How has BRIBF Enterprise Value performed in the past?

The mean historical Enterprise Value of Brii Biosciences Limited over the last ten years is 6.69B. The current -394860553.00 Enterprise Value has changed -690.40% with respect to the historical average. Over the past ten years (40 quarters), BRIBF's Enterprise Value was at its highest in in the December 2020 quarter at 11.92B. The Enterprise Value was at its lowest in in the March 2022 quarter at -2957991000.00.

Brii Biosciences Limited (BRIBF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Brii Biosciences Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Brii Biosciences Limited (BRIBF) Average Enterprise Value

How has BRIBF Enterprise Value performed in the past?

The current Enterprise Value of Brii Biosciences Limited (BRIBF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Brii Biosciences Limited (BRIBF) Enterprise Value vs. Peers

How is BRIBF’s Enterprise Value compared to its peers?

Brii Biosciences Limited’s Enterprise Value is less than Avalo Therapeutics, Inc. (-2649000.00), less than Alzamend Neuro, Inc. (5.54M), less than Virax Biolabs Group Limited (8.31M), less than Kiromic BioPharma, Inc. (11.80M), less than Benitec Biopharma Inc. (70.52M), less than Cardio Diagnostics Holdings, Inc. (6.14M), less than Sigilon Therapeutics, Inc. (43.98M), less than Sonnet BioTherapeutics Holdings, Inc. (1.80M), less than ZyVersa Therapeutics, Inc. (2.49M), less than X4 Pharmaceuticals, Inc. (49.50M), less than Terns Pharmaceuticals, Inc. (770.84M), less than 89bio, Inc. (695.24M), less than Cabaletta Bio, Inc. (47.63M), less than Akero Therapeutics, Inc. (1.60B), less than Mirum Pharmaceuticals, Inc. (1.89B), less than Inozyme Pharma, Inc. (395.96M), less than Day One Biopharmaceuticals, Inc. (970.79M), less than HOOKIPA Pharma Inc. (83.21M), less than Axsome Therapeutics, Inc. (4.27B), less than Incyte Corporation (11.60B), less than ImmunoGen, Inc. (8.19B), less than Sarepta Therapeutics, Inc. (12.91B), less than ACADIA Pharmaceuticals Inc. (2.59B),

Build a custom stock screener for Brii Biosciences Limited (BRIBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Brii Biosciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Brii Biosciences Limited (BRIBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Brii Biosciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.